In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Objectives The aims of this study were to examine variation in the use of conscious sedation
(CS) for transcatheter aortic valve replacement (TAVR) across hospitals and over time and to …

Aims Transcatheter aortic valve replacement (TAVR) as an alternative to surgical aortic
valve replacement (SAVR) has profoundly changed the management of patients with aortic …

Aims: Treatment pathway optimisation in TAVI should include timely patient discharge with a
minimised risk for out-of-hospital adverse events. The aim of this study was to define a …

Objectives The aim of this study was to compare outcomes after transcatheter aortic valve
replacement (TAVR) with the SAPIEN 3 Ultra (Ultra) and SAPIEN 3 (S3) transcatheter heart …

Background Procedural success and clinical outcomes after transcatheter aortic valve
replacement (TAVR) have improved, but residual aortic regurgitation (AR) and new …

Patients with structural heart disease are at increased risk of adverse outcomes from the
coronavirus disease-2019 (COVID-19) due to advanced age and comorbidity. In the midst of …

Objectives This study evaluated the feasibility and safety of same-day discharge (SDD)
following transfemoral transcatheter aortic valve replacement (TF-TAVR) compared with next …